Related Experiment Video
Updated: Feb 26, 2026

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Associations between drugs and small-bowel mucosal bleeding: Multicenter capsule-endoscopy study.
Ryota Niikura1, Atsuo Yamada1, Koutarou Maki2
1Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of small-bowel mucosal injury. However, NSAID use was not significantly associated with overt small-bowel bleeding in this patient population.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Several drugs can cause small-bowel mucosal injuries.
- The link between drug-induced injuries and overt small-bowel bleeding remains unclear.
Purpose of the Study:
- To investigate the association between drug use and small-bowel mucosal injury.
- To determine if these mucosal injuries correlate with overt small-bowel bleeding.
Main Methods:
- Retrospective analysis of 850 patients undergoing capsule endoscopy (2010-2013).
- Assessment of drug exposure, comorbidities, smoking, and alcohol consumption.
- Estimation of adjusted odds ratios (AOR) for mucosal injury and bleeding.
Main Results:
- Non-steroidal anti-inflammatory drug (NSAID) use was significantly associated with an increased risk of small-bowel mucosal injury (AOR 1.8, 95% CI 1.01-3.31).
- No significant association was found between NSAID use and overt small-bowel bleeding.
- No significant differences in drug usage rates (including NSAIDs, antiplatelets, anticoagulants, steroids) were observed between patients with and without overt bleeding.
Conclusions:
- NSAID use is a significant risk factor for developing small-bowel mucosal injury.
- Current evidence does not support a direct link between NSAID use and overt small-bowel bleeding.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Endoscopic Procedures III: Video Capsule Endoscopy
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS